Scientists pinpoint ideal sedative dose for sleep apnea scopes
NCT ID NCT06333145
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This trial aims to find the 90% effective dose of remimazolam, a sedative, for drug-induced sleep endoscopy in adults. The study includes people of different body sizes to see if the ideal dose varies. Participants will receive remimazolam and be monitored for sedation success and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
remimazolam
What this could lead to
If successful, this could help doctors use the right dose of remimazolam for sedation during sleep endoscopy, improving safety and effectiveness.
What could go wrong
This is a small, early-phase trial focused on dosing, not on treating a disease. Results may not apply to all patients or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EFFECT OF DRUG are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tongji Hospital
Wuhan, Hubei, 430000, China